AstraZeneca PLC Logo

AstraZeneca PLC Claim profile

ISIN: GB0009895292 | Ticker: AZN | LEI: PY6ZZQWO2IZFZC3IOL08

About AstraZeneca PLC

Company Description

We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science can do.

We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally. We have three priorities designed to deliver our growth through innovation strategy.

Oncology
We are leading a revolution in oncology to redefine cancer care. Our ambition is to provide cures for cancer in every form.

BioPharmaceuticals
We want to change the lives of billions of people living with chronic diseases for the better.

Rare Disease
Our mission is to transform the lives of people affected by rare diseases and devastating conditions.

Year founded

1999

Served area

Worldwide

Headquarters

1 Francis Crick Avenue, CB2 0AA Cambridge – United Kingdom

Filings & Publications

2022

Report Q1 H1 Q3 FY
Consolidated Report ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2021

Report Q1 H1 Q3 FY
Consolidated Report ENG
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will inform you!

Shareholder information

Shares outstanding

1,549,800,030

IPO

June 1, 1993

Stock exchange(s)

London Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.